News: UCM Uscom Ltd Announces Extension Of Its Ongoing Partnership With Koneksa, page-13

Dideoxy- thanks for reference to digital health article. Ehealth is obviously a significant growth area so hopefully the spirosonic air is part of it.
company published some possible revenue numbers in its August presentation. Was a big prediction jump in revenue from 2021 to 2022. Wondering after the poor first quarter if that has changed.
part of that increase was a predicted strong increase in sales of bp+ which for many years has had extremely poor sales to me. Only contributed 4% in 2020.
bp+ was approved in China in mid April but seems the 5 months up until the end of the sept quarter it may not have made an immediate impact if the first quarter sales are an indication. Was hoping the company had done a tone of pre sales planning for immediate sales but hoping the sales pick up strongly as their model had hoped.
Seems as if the 1a is going to have to continue to do the heavy sales lifting and hopefully improve its sales also whilst we await the other products to join the party.